RxDoctor Payments Data

David Ophoff, PA

Physician Assistant · Grand Rapids, MINPI 1821379132

Payments from drug & device makers

$7,082in general payments, 2019–2025

Across 54 payments — averaging $131.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$7K
  • Novo Nordisk$134
  • AbbVie$89
  • Takeda Pharmaceuticals U.S.A., Inc.$85
  • Madrigal Pharmaceuticals$19
  • Sanofi$19
  • plus $16 from 1 others

What the payments were for

  • Consulting fees$4,25060%
  • Travel & lodging$1,66924%
  • Food & beverage$1,07915%
  • Education$851%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,082 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$16,158
Medicare patients
155
Services billed
182

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpclusaSofosbuvir/Velpatasvir11$244,200
LinzessLinaclotide63$48,926
Mesalamine15$2,926
Lubiprostone11$2,869
Esomeprazole Magnesium58$1,760
Budesonide DrBudesonide17$1,663
Colesevelam Hcl14$1,317
Omeprazole53$920
Rabeprazole Sodium25$798
Dicyclomine Hcl29$783
Pantoprazole Sodium24$568
Famotidine45$410
Nortriptyline Hcl11$229
Spironolactone15$108
Metoclopramide Hcl15$58

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$89$48,92663 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →